Published in J Neural Transm (Vienna) on May 01, 2015
A quantitative study of tau pathology in eleven cases of chronic traumatic encephalopathy. Neuropathol Appl Neurobiol (2016) 0.76
Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology. J Neurosci (2016) 0.75
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry (1957) 18.90
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun (1984) 8.14
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (2006) 4.24
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology (1988) 3.87
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol (2003) 3.47
Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 3.20
TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem (2007) 2.91
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol (2006) 2.43
Hippocampus as comparator: role of the two input and two output systems of the hippocampus in selection and registration of information. Hippocampus (2001) 2.41
Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res (2007) 2.38
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci (2010) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Frontal-hippocampal double dissociation between normal aging and Alzheimer's disease. Cereb Cortex (2004) 1.91
Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol (2007) 1.68
Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest (1997) 1.66
Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain (2001) 1.59
alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol (2004) 1.53
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord (1995) 1.43
Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging (2006) 1.40
Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience (1987) 1.38
Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology (2000) 1.34
Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (1998) 1.31
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res (1992) 1.30
NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron (2009) 1.29
A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ (2011) 1.27
Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Arch Neurol (2012) 1.26
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology (1999) 1.24
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol (1995) 1.22
Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol (2004) 1.19
Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol (2001) 1.18
Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (1992) 1.18
Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol (1994) 1.16
Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm (Vienna) (2009) 1.14
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain (2011) 1.08
Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol (2010) 1.07
A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord (2001) 1.05
Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol (1994) 1.04
The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old. Acta Neuropathol (2000) 1.03
Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology (2003) 1.03
Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch Neurol (1995) 1.02
Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann Neurol (1999) 1.00
Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cereb Cortex (1994) 0.99
Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study. Acta Neuropathol (2004) 0.99
Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol (1992) 0.98
Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging. Exp Gerontol (2000) 0.96
Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol (1992) 0.95
Clinicopathologic correlation in PGRN mutations. Neurology (2007) 0.95
The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol (1996) 0.95
What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology (2008) 0.95
A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm (Vienna) (2013) 0.93
Differing profiles of face and scene discrimination deficits in semantic dementia and Alzheimer's disease. Neuropsychologia (2007) 0.92
Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (1997) 0.89
MMSE scores decline at a greater rate in frontotemporal degeneration than in AD. Dement Geriatr Cogn Disord (2006) 0.88
Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett (2003) 0.88
Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET. Eur J Neurol (2011) 0.87
Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol (2001) 0.87
Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer's disease, Lewy body disease and progressive supranuclear palsy. Acta Neuropathol (1997) 0.87
Calretinin-immunoreactive neurons are resistant to beta-amyloid toxicity in vitro. Brain Res (1995) 0.86
Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 0.85
Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex. Neuroscience (2005) 0.85
Functional imaging as a window to dementia: corticobasal degeneration. J Neuropsychiatry Clin Neurosci (2004) 0.85
Morphological differences of intraneuronal ubiquitin-positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology (2004) 0.84
Induction of beta-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp Neurol (1994) 0.83
Temporal lobe pathology of human patients with neurofilament inclusion disease. Neurosci Lett (2004) 0.82
A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA). J Neural Transm (Vienna) (2004) 0.81
Laminar distribution of pick bodies, pick cells and Alzheimer disease pathology in the frontal and temporal cortex in Pick's disease. Neuropathol Appl Neurobiol (1999) 0.81
Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA). J Neural Transm (Vienna) (2005) 0.81
MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease. Neuroradiology (2001) 0.80
Tau-positive grains are constant in centenarians' hippocampus. Neurobiol Aging (2009) 0.80
Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Neurosci Lett (1994) 0.80
Grey matter changes in cognitively impaired Parkinson's disease patients. PLoS One (2014) 0.79
Neuronal inclusions in the dentate fascia in patients with multiple system atrophy. Neurosci Lett (1997) 0.79
Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia (1995) 0.78
Cognitive function and psychiatric symptoms in early- and late-onset frontotemporal dementia. Dement Geriatr Cogn Disord (2008) 0.78
Resistance of the hippocampus in Creutzfeldt-Jakob disease. Clin Neuropathol (1997) 0.78
Non-Alzheimer fronto-temporal degenerative dementia. A neurobehavioral and pathologic study. Clin Neuropathol (1994) 0.78
Brain volumetry in Parkinson's disease with and without dementia: where are the differences? Acta Radiol (2013) 0.78
[(123)I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6). Neuroimage Clin (2013) 0.78
Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex--a study in ten patients. Clin Neuropathol (2005) 0.78
Frontotemporal dementia with ubiquitinated neuronal inclusions and visuospatial impairment. Neurology (2005) 0.78
Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease. Acta Neuropathol (1999) 0.77
Pick's disease: alpha- and beta-synuclein-immunoreactive Pick bodies in the dentate gyrus. Acta Neuropathol (2002) 0.77
Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol (2009) 0.77
Subcortical structures in progressive supranuclear palsy: vertex-based analysis. Eur J Neurol (2012) 0.75
Regional differences in reactive gliosis induced by substrate-bound beta-amyloid. Exp Neurol (1994) 0.75
Beta-amyloid (beta/A4) deposition in the medial temporal lobe in Down's syndrome: effects of brain region and patient age. Neurobiol Dis (1994) 0.75
Atypical diffuse Lewy body disease with neuritic abnormalities. Clin Neuropathol (1994) 0.75
Laminar degeneration of frontal and temporal cortex in Parkinson disease dementia. Neurol Sci (2017) 0.78
Clustering of tau-immunoreactive pathology in chronic traumatic encephalopathy. J Neural Transm (Vienna) (2016) 0.75
Erratum to: Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders. J Neural Transm (Vienna) (2015) 0.75